Carregant...
Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time
BACKGROUND: The chromogenic anti‐Xa assay, the gold standard for monitoring the anti‐Xa effect of rivaroxaban, is not available as a cage‐side diagnostic test for use in a clinical setting. HYPOTHESIS/OBJECTIVES: To evaluate clinical modalities for measuring the anticoagulant effects of rivaroxaban...
Guardat en:
| Publicat a: | J Vet Intern Med |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524124/ https://ncbi.nlm.nih.gov/pubmed/30859645 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15478 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|